Table 1.
Changes to Health Canada restrictive measures for mifepristone-misoprostol medical abortion
| Topic | Change | Date changed |
|---|---|---|
| Observed ingestion | Removed requirement for observation of mifepristone ingestion. The patient can take the medication where and when they choose. | Oct 2016 |
| Training | Removed requirement for training for pharmacists. | May 2017 |
| Training | Removed requirement for training for prescribers. | November 2017 |
| Consent form | Removed requirement for a manufacturer consent form to be signed by the patient. | November 2017 |
| Registration | Removed requirement for registration of prescribers or pharmacists with the manufacturer. | November 2017 |
| Dispensing | Mifepristone can be dispensed directly to patients by a pharmacist or prescribing health professional, rather than the original requirement that a physician must dispense directly to the patient. | November 2017 |
| Gestational age | Mifepristone-misoprostol may be used up to 9 weeks (63 days) from last menstrual period, rather than the original 7 weeks (49 days). | November 2017 |
| Ultrasound | Removed requirement for mandatory ultrasound prior to prescribing. | April 2019 |
Source: Munro et al. [13]